Cognitive & Neuroprotective

Cerebrolysin

Also known as: FPF-1070

Overview

Mixture of neuropeptides and low molecular weight amino acids derived from porcine brain. Contains neurotrophic factors that mimic BDNF, GDNF, and CNTF. Studied for neuroprotection and cognitive recovery.

Complex mixture of low molecular weight peptides. Exact composition not defined by a single sequence.

Half-life

~3-5 hours

Administration Route

Intramuscular or intravenous

Category

Cognitive & Neuroprotective

Mechanism of Action

  • Neurotrophic activity mimicking BDNF and GDNF
  • Promotion of neurogenesis and synaptogenesis
  • Neuronal anti-apoptotic effect
  • Modulation of neuroinflammation
  • Improvement of synaptic plasticity

Dosage Protocol

Data compiled from the literature. This does not constitute medical advice.

Parameter Value
Dose 5-30 ml per injection
Frequency Once daily
Timing Morning
Duration 10-20 days (repeated cycles)

Reported Side Effects

Adverse effects described in the literature. Severity and frequency vary between individuals.

  • Headache
  • Dizziness
  • Agitation
  • Injection site pain
  • Insomnia (rare)

Presentations & Preparation

Vials of Cerebrolysin found in the research market:

1 ml5 ml10 ml30 ml

Reconstitution

  • Diluent: N/A (ready-to-use solution)
  • Volume: N/A
  • Product supplied in ready-to-use ampoules
  • Clear yellowish solution

Storage

  • Lyophilized: Room temperature (up to 3 years)
  • Reconstituted: N/A (sealed ampoules)
  • Protect from light
  • Do not use if the solution is cloudy
Reconstitution Calculator

Related Peptides

Adamax

100-500 mcg via intranasal or subcutaneous · 1-2 times daily

Cortagen

5-10 mg per day via subcutaneous injection · Once daily

Dihexa

10-20 mg per subcutaneous injection or oral (research) · Once daily

DSIP

100-300 mcg per subcutaneous injection · Once daily

Epithalon

5-10 mg per injection · Once daily or every other day

FG Loop

5-10 mg per subcutaneous injection · Once daily or every other day